Ignite Creation Date:
2025-12-24 @ 12:07 PM
Ignite Modification Date:
2026-03-02 @ 5:52 PM
Study NCT ID:
NCT04253561
Status:
UNKNOWN
Last Update Posted:
2023-04-18
First Post:
2020-01-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients
Sponsor:
SOLTI Breast Cancer Research Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SOLTI-1507
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |